BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)
Clinical trial NCT04839471 · COMPLETED
Trial details
- NCT number
- NCT04839471
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2023-07-24
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.